Kootenay Confirms Paid Promotion and Replies to OTC Markets — Why Small‑cap Investors Should Pay Attention

This article was written by the Augury Times
Short answer: Kootenay admits it hired an external promoter and told OTC Markets the work was paid and arm’s‑length
Kootenay (KTN / KOOYF) has confirmed that it hired a third‑party promoter and has formally responded to questions from OTC Markets. In a December filing, the company said it engaged Sideways Frequency LLC to carry out paid promotional activity and that the arrangement was made at arm’s length. The response comes after OTC Markets asked for more information about recent promotional campaigns tied to the company’s securities.
A clear timeline from the hiring to the December response
The first public signal came earlier this fall when Kootenay announced an engagement with outside marketing help on Sept. 8, 2025. That statement was broad and did not include many contractual details. On Dec. 17, Kootenay filed a more detailed disclosure saying the company had engaged Sideways Frequency LLC and specifying the nature of the work as paid promotional activity.
Following that filing, OTC Markets sent a request for information. Kootenay replied to the exchange’s questions in writing, confirming the engagement, describing the services as promotional, and asserting that the contract was arm’s‑length. The company’s December disclosure and its reply to OTC Markets are the official record so far; both documents focus on confirming the engagement and the paid nature of the work rather than revealing every term of the deal.
What Sideways Frequency LLC was hired to do — and what Kootenay didn’t fully disclose
Kootenay says Sideways Frequency LLC was retained to perform paid promotional activity on behalf of the company. The filing frames the relationship as commercial and arm’s‑length, meaning the parties are not related by ownership or control. That language is meant to reassure regulators and investors that the promoter is an independent contractor.
But the disclosure leaves some gaps. Kootenay’s filing does not fully spell out the campaign’s scope, the exact duration, or precise compensation details. There’s mention of paid promotion, but not a breakdown of fees, performance triggers, or termination rights. Those missing pieces are the details regulators often want when judging whether a promotion could have misled the market or unintentionally inflated trading activity.
Why OTC Markets stepped in and what could follow
OTC Markets routinely asks questions when it sees aggressive publicity tied to smaller listings. Their concern is simple: paid promotions can push attention and trading, and without solid disclosure, they can mislead buyers. The exchange’s inquiry aims to confirm that investors knew what was happening and that the company followed disclosure rules.
Possible outcomes range from a clean close of the file to follow‑up requests asking for the full contract, payment records, or communications between the issuer and promoter. In more serious cases, OTC Markets can flag the issuer’s profile for investors, which tends to reduce liquidity, or refer issues to securities regulators if there’s evidence of misleading statements or market manipulation.
How this can move Kootenay’s share price and investor confidence
Paid promotions can produce short‑term spikes in volume and price for small‑cap metals explorers like Kootenay. That’s especially true on thinly traded markets where a single campaign can drive outsized attention. But the pattern often reverses: once the promotional push fades or regulators probe the activity, volume can drop and prices can pull back quickly.
For current and prospective shareholders, the risk is twofold. First, there’s price risk: shares can be volatile and may trade on publicity rather than fundamentals. Second, there’s reputational and regulatory risk: a formal warning from OTC Markets or a regulator can make it harder for the company to attract long‑term capital and may limit trading windows. Given those factors, the situation looks risky for short‑term momentum traders and mixed for longer‑term holders who care about project progress and financing plans.
What to watch next
Investors and reporters should track a few items: any follow‑up filings from Kootenay that add contract detail; further correspondence or rulings from OTC Markets; unusual trading patterns in KTN or KOOYF; and any regulatory steps from securities commissions. If additional disclosures show clear, transparent terms and no misleading claims, the issue may fade. If not, expect sharper scrutiny and potential damage to liquidity and investor confidence.
Sources
Comments
More from Augury Times
SNB’s latest BoP shows big swings in cross‑border flows — what it means for the franc and markets
Switzerland’s balance of payments and IIP moved sharply this quarter. Here’s a plain‑English look at what changed, why, and what investors should watch next.…

Cipollone’s Playbook for Money: How the ECB’s view on CBDCs and payments could shift markets
Piero Cipollone’s recent speech laid out a cautious, practical path for central-bank digital currency, payments safety and monetary-policy ties. Here’s what investors and policymak…

Crypto exec says moving Bitcoin to post‑quantum security could take years — why investors should care
A crypto executive told Cointelegraph that migrating Bitcoin to post‑quantum cryptography may take 5–10 years. Here’s what that means for holders, custodians and markets.…

ECB wage tracker points to cooling pay pressures — markets brace for a gentler 2026 normalisation
The ECB’s new wage tracker shows slower pay growth and easing negotiated wage deals, nudging markets toward a softer 2026 rate path. Here’s what investors should watch.…
Augury Times

Law Firm Files Suit Against Coupang — Investors Urged to Consider Joining Class Over Alleged Misstatements
Bronstein, Gewirtz & Grossman says a class action has been filed against Coupang (CPNG) alleging investor harm. What…

Samsung Biologics buys GSK’s U.S. site — a fast track into American drugmaking, with a long list of tasks ahead
Samsung Biologics’ purchase of GSK’s Human Genome Sciences site gives it a U.S. manufacturing foothold. Here’s why the…

SVN Sets Online Auction for 24‑Unit Baton Rouge Apartment Building in Early January
SVN announced an online auction for a 24‑unit apartment property in Baton Rouge with bidding scheduled for the first…

Investors Brace as Rosen Law Firm Opens Inquiry Into New Era Energy & Digital
Rosen Law Firm has launched a securities class action investigation into New Era Energy & Digital (NUAI). Here’s what…

How Tokenization Could Rewire Finance — and What Investors Should Watch Next
A crypto executive says tokenization will upend finance faster than digital reshaped media. Here’s how tokenized…

Big Crypto Fight: Terraform Sues Jump Trading — Why this lawsuit matters to traders and markets
Terraform Labs has filed a multi‑billion dollar suit against Jump Trading, accusing the firm of profiting from the…